NEUROSENSE THERAPEUTICS LTD(NASDAQ:NRSN) stock Analyst Ratings

Buy % Consensus

ChartMill assigns a Buy % Consensus number of 80% to NRSN. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 14.28. This target is 1080.17% above the current price.

NRSN was analyzed by 9 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about NRSN.

In the previous month the buy percentage consensus was at a similar level.

NRSN was analyzed by 9 analysts. More opinions would make the average more meaningful.

Price

Low

Median

Mean

High

1.21

14.14

14.28

14.70

1,068.60%

1,080.17%

1,114.88%

Up and Down Grades

Date	Firm	Action	Rating
2025-08-15	D. Boral Capital	Maintains	Buy -> Buy
2025-07-10	D. Boral Capital	Maintains	Buy -> Buy
2025-05-12	D. Boral Capital	Initiate	Buy
2024-12-16	Maxim Group	Downgrade	Buy -> Hold
2023-07-17	Alliance Global Partners	Initiate	Buy
2022-01-07	Maxim Group	Initiate	Buy

NEUROSENSE THERAPEUTICS LTD (NRSN) Stock Analyst Ratings